Data breach at Dr Reddy’s forces lab to temporarily shot operations across globe | Health - Hindustan Times
close_game
close_game

Data breach at Dr Reddy’s forces lab to temporarily shot operations across globe

Hindustan Times, New Delhi | By
Oct 22, 2020 03:48 PM IST

The Hyderabad-based lab is authorised to test and distribute the Russian Covid-19 vaccine in India

After reports of a data leak from Hyderabad-based global pharmaceutical company Dr Reddy’s Laboratories Ltd, one of country’s leading pathology laboratory chains came out, IT has been forced to temporarily shut operations in its plants across the world.

Dr Reddy’s Laboratories had recently received approval from the drugs controller general of India to conduct an adaptive phase 2/3 clinical trial in India for Russia’s Sputnik V vaccine candidate against Coronavirus disease (Covid-19).(REUTERS File)
Dr Reddy’s Laboratories had recently received approval from the drugs controller general of India to conduct an adaptive phase 2/3 clinical trial in India for Russia’s Sputnik V vaccine candidate against Coronavirus disease (Covid-19).(REUTERS File)

Apart from its plant in India, the other plants that have shut include the ones at Brazil, Russia, the United Kingdom and the United States. The breach is reported to have taken place early (India time) Thursday.

Unlock exclusive access to the story of India's general elections, only on the HT App. Download Now!

Dr Reddy’s Laboratories had recently received approval from the drugs controller general of India to conduct an adaptive phase 2/3 clinical trial in India for Russia’s Sputnik V vaccine candidate against Coronavirus disease (Covid-19).

Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, last month announced that it had inked a deal with India’s Dr Reddy’s for the trial and distribution of their vaccine candidate in India.

Upon regulatory approvals in India, RDIF shall supply 100 million doses of the vaccine to Dr Reddy’s.

According to RDIF, deliveries could potentially begin in late 2020, subject to the completion of successful trials and registration of the vaccine by regulatory authorities in India.

On August 11, the Sputnik V vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia.

The company is reviewing what led to the data breach.

Mukesh Rathi, CIO, Dr. Reddy’s issued a statement in the matter as reported by the website moneycontrol.com.

“In the wake of a detected cyber-attack, we have isolated all data centre services to take required preventive actions. We are anticipating all services to be up within 24 hours and we do not foresee any major impact on our operations due to this incident.”

The shares of Dr Reddy’s declined by nearly 3% following the report of data breach.

Oscars 2024: From Nominees to Red Carpet Glam! Get Exclusive Coverage on HT. Click Here

Catch your daily dose of Fashion, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
SHARE THIS ARTICLE ON
Share this article
  • ABOUT THE AUTHOR
    author-default-90x90

    Rhythma Kaul works as an assistant editor at Hindustan Times. She covers health and related topics, including ministry of health and family welfare, government of India.

SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, April 11, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On